Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • benimmyeo
    Junior Member
    • Dec 2008
    • 3

    Sequence and structural variation in a human genome uncovered by short-read, massivel

    Sequence and structural variation in a human genome uncovered by short-read, massively parallel ligation sequencing using two base encoding

    Kevin Judd McKernan1,7, Heather E. Peckham1, Gina Costa1, Stephen McLaughlin1, Eric Tsung1, Yutao Fu1, Christopher Clouser1, Cisyla Dunkan1, Jeffrey Ichikawa1, Clarence Lee1, Zheng Zhang1, Andrew Sheridan1, Haoning Fu1, Swati Ranade1, Eileen Dimilanta1, Tanya Sokolsky1, Lei Zhang1, Cynthia Hendrickson2, Bin Li1, Lev Kotler1, Jeremy Stuart1, Joel Malek3, John Manning1, Alena Antipova1, Damon Perez1, Michael Moore1, Kathleen Hayashibara1, Michael Lyons1, Robert Beaudoin1, Brittany Coleman1, Michael Laptewicz1, Adam Sanicandro1, Michael Rhodes1, Francisco De La Vega1, Rajesh K. Gottimukkala1, Fiona Hyland1, Michael Reese1, Shan Yang1, Vineet Bafna4, Ali Bashir4, Andrew MacBride5, Can Aklan6, Jeffrey M Kidd6, Evan E Eichler6 and Alan Phillip Blanchard1
    +Author Affiliations



    Abstract
    We describe the genome sequencing of an anonymous individual of African origin using a novel ligation based sequencing assay that enables a unique form of error correction that improves the raw accuracy of the aligned reads to >99.9% allowing us to accurately call SNPs with as few as 2 reads per allele. We collected several billion mate-pair reads yielding ~18× haploid coverage of aligned sequence and close to 300× clone coverage. Over 98% of the reference genome is covered with at least one uniquely placed read and 99.65% spanned by at least one uniquely placed mate-paired clone. We identify over 3.8 million SNPs, 19% of which are novel. Mate-paired data is used to physically resolve haplotype phases of nearly 2/3 of the genotypes obtained and produce phased segments of up to 210 Kb. We detect 226,529 intra-read indels, 5,590 indels between mate-paired reads, 91 inversions and 4 gene fusions. We use a novel approach for detecting indels between mate-paired reads that are smaller than the standard deviation of the insert size of the library and discover deletions in common with those detected with our intra-read approach. Dozens of previously described disease susceptibility mutations and thousands of novel potentially functional variants, both single-nucleotide and structural, are identified in this individual which suggests a higher than expected load of deleterious variants that can be tolerated in the human genome. There is more genetic variation in the human genome still to be uncovered and we provide guidance for future surveys in populations and cancer biopsies.

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
38 views
0 reactions
Last Post SEQadmin2  
Working...